- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1869-1889
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Armed T cells with CAR for cancer immunotherapy ; volume:59 ; number:4 ; day:15 ; month:4 ; year:2016 ; pages:331-332 ; date:4.2016
Science China / Life sciences. Life sciences ; 59, Heft 4 (15.4.2016), 331-332, 4.2016
- Creator
-
Wei, Yu-quan
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11427-016-5047-0
- URN
-
urn:nbn:de:1111-2016041616039
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wei, Yu-quan
- SpringerLink (Online service)
Other Objects (12)
Nanobody-based CAR-T cells for cancer immunotherapy
CAR-NK cells for cancer immunotherapy: from bench to bedside
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy
Potential solutions for manufacture of CAR T cells in cancer immunotherapy
CAR-NK cells for gastrointestinal cancer immunotherapy: from bench to bedside
Enhancing CAR T cells function: role of immunomodulators in cancer immunotherapy
New cell sources for CAR-based immunotherapy
Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors
Nanobody-armed T cells endow CAR-T cells with cytotoxicity against lymphoma cells
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy
Nanobody-based CAR-T cells for cancer immunotherapy
CAR-NK cells for cancer immunotherapy: from bench to bedside
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy
Potential solutions for manufacture of CAR T cells in cancer immunotherapy
CAR-NK cells for gastrointestinal cancer immunotherapy: from bench to bedside
Enhancing CAR T cells function: role of immunomodulators in cancer immunotherapy
New cell sources for CAR-based immunotherapy
Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors
Nanobody-armed T cells endow CAR-T cells with cytotoxicity against lymphoma cells
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy
Nanobody-based CAR-T cells for cancer immunotherapy
CAR-NK cells for cancer immunotherapy: from bench to bedside
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy
Potential solutions for manufacture of CAR T cells in cancer immunotherapy
CAR-NK cells for gastrointestinal cancer immunotherapy: from bench to bedside
Enhancing CAR T cells function: role of immunomodulators in cancer immunotherapy
New cell sources for CAR-based immunotherapy
Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors
Nanobody-armed T cells endow CAR-T cells with cytotoxicity against lymphoma cells
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors